Retinoids in nephrology: Promises and pitfalls

Slides:



Advertisements
Similar presentations
Volume 56, Issue 5, Pages (November 1999)
Advertisements

Volume 68, Issue 2, Pages (August 2005)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 60, Issue 2, Pages (August 2001)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Myocardin-Related Transcription Factors A and B Are Key Regulators of TGF-β1- Induced Fibroblast to Myofibroblast Differentiation  Beverly J. Crider, George.
Volume 88, Issue 4, Pages (October 2015)
Volume 70, Issue 5, Pages (September 2006)
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Volume 67, Issue 3, Pages (March 2005)
Hadas Ben-Sasson, M. Sc. , Assaf Ben-Meir, M. D. , Asher Shushan, M. D
Human mesangial cells express inducible macrophage scavenger receptor
Volume 69, Issue 8, Pages (April 2006)
Epidermal Growth Factor Induces Fibronectin Expression in Human Dermal Fibroblasts via Protein Kinase C δ Signaling Pathway  Yoshihiro Mimura, Hironobu.
Volume 60, Issue 5, Pages (November 2001)
Volume 60, Issue 2, Pages (August 2001)
Dysregulation of LDL receptor under the influence of inflammatory cytokines: A new pathway for foam cell formation1  Dr Xiong Z. Ruan, Zac Varghese, Stephen.
Volume 66, Issue 6, Pages (December 2004)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 62, Issue 4, Pages (October 2002)
Volume 54, Issue 1, Pages (July 1998)
Volume 56, Issue 5, Pages (November 1999)
Volume 53, Issue 5, Pages (May 1998)
Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-α–activated human peritoneal mesothelial.
Volume 67, Issue 6, Pages (June 2005)
Wolfgang Eberhardt, Karl-Friedrich Beck, Josef Pfeilschifter 
Volume 64, Issue 5, Pages (November 2003)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Shiga toxin 1 elicits diverse biologic responses in mesangial cells
Volume 85, Issue 3, Pages (March 2014)
Suppression of Vitamin D Receptor and Induction of Retinoid X Receptor α Expression During Squamous Differentiation of Cultured Keratinocytes  Siegfried.
Volume 64, Issue 2, Pages (August 2003)
Izabella Z.A. Pawluczyk, Samita R. Patel, Kevin P.G. Harris 
Volume 56, Issue 3, Pages (September 1999)
Inhibition of glomerular cell apoptosis by heparin
Heparin-Binding Epidermal-Growth-Factor-Like Growth Factor Activation of Keratinocyte ErbB Receptors Mediates Epidermal Hyperplasia, a Prominent Side-Effect.
Volume 54, Issue 4, Pages (October 1998)
Volume 68, Issue 2, Pages (August 2005)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 62, Issue 3, Pages (September 2002)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
Volume 58, Pages S19-S25 (September 2000)
Xiangmei Chen, Wenhu Liu, Jianzhong Wang, Xiaodan Wang, Zhiheng Yu 
Volume 73, Issue 1, Pages (January 2008)
Bisphosphonate safety and efficacy in chronic kidney disease
Jin H. Li, Xiao R. Huang, Hong-Jian Zhu, Richard Johnson, Hui Y. Lan 
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Volume 61, Issue 6, Pages (June 2002)
Volume 62, Issue 5, Pages (November 2002)
Volume 62, Pages S12-S22 (December 2002)
Yoshihisa Ishikawa, Masanori Kitamura  Kidney International 
Retinoic Acid Synthesis and Signaling during Early Organogenesis
Izabella Z.A. Pawluczyk, Samita R. Patel, Kevin P.G. Harris 
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 61, Issue 6, Pages (June 2002)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Volume 64, Issue 6, Pages (December 2003)
Prasun K. Datta, Elias A. Lianos  Kidney International 
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 80, Issue 10, Pages (November 2011)
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 55, Issue 2, Pages (February 1999)
J. Martin, T. Bowen, R. Steadman  Kidney International 
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
Volume 72, Issue 2, Pages (July 2007)
Volume 68, Issue 2, Pages (August 2005)
Differential effects of simvastatin on mesangial cells
Presentation transcript:

Retinoids in nephrology: Promises and pitfalls Qihe Xu, Javier Lucio-Cazana, Masanori Kitamura, Xiongzhong Ruan, Leon G. Fine, Jill T. Norman  Kidney International  Volume 66, Issue 6, Pages 2119-2131 (December 2004) DOI: 10.1111/j.1523-1755.2004.66002.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Biological and pharmacologic functions of natural retinoids. The majority of the functions of vitamin A (retinol) are RA-dependent. Vitamin A does not bind RAR and RXR, but RAs do. The conversion of vitamin A to RAs is catalyzed by ADHs and RALDHs via a reversible oxidation and an irreversible oxidation, respectively. The majority of the functions of RAs are nuclear receptor–dependent by initiation of target gene expression or cross-talk with other transcription factors, such as AP-1. RAs also targets nuclear receptors, kinases, and other protein substrates and, therefore, have RAR- and RXR-independent functions. These mechanisms explain why RAs play important roles in multiple biological and pharmacologic processes, especially during renal development and in kidney diseases. The metabolism and inactivation of RAs is catalyzed by a group of cytochrome P450 (Cyp) enzymes. For example, metabolism of tRA is mainly mediated by Cyp26A and B. Kidney International 2004 66, 2119-2131DOI: (10.1111/j.1523-1755.2004.66002.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Effects of tRA on TGFβ-induced fibronectin mRNA expression in human renal fibroblasts. Confluent human renal fibroblasts were made quiescent in DMEM:Ham's F12 (1:1) medium containing 0.1% fetal calf serum (FCS) for 48 hours before being treated with 5 ng/mL TGFβ1 for 24 hours and 48 hours in the absence or presence of 1 μmol/L tRA. Total RNA was extracted and subjected to Northern hybridization for fibronectin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNAs. A representative Northern blot of cells treated for 24 hours is shown (48-hour experiments show a similar trend; data not shown). Kidney International 2004 66, 2119-2131DOI: (10.1111/j.1523-1755.2004.66002.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Different effects of retinoids on varying groups of proinflammatory factors might contribute to the different responses of renal diseases to retinoid treatment. Inflammatory factors are theoretically divided into three groups, which respond differentially to RA treatment, namely, RAs suppress group A, induce group C, and have little influence on group B. Consequently, the group A and group D diseases that are mediated by group A or group A plus group B inflammatory factors are good indicators for RA treatment; the group B diseases that are solely mediated by group B inflammatory factors are not responsive to RAs; the group C and group E diseases that are mediated by group C inflammatory factors only or by group C plus group B factors are not indicators for retinoid treatment, and may even be exacerbated by retinoids. The group F diseases that are mediated by both group A and group C inflammatory factors may become resistant to RAs, or may respond to retinoids, but at the same time develop some inflammatory side effects. The solid line with a circled ‘minus’ indicates a suppression; the solid line with a circled ‘plus’ stands for induction. The dashed line indicates no interaction. Kidney International 2004 66, 2119-2131DOI: (10.1111/j.1523-1755.2004.66002.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 The effects of tRA and dexamethasone (Dex) on MIF mRNA expression in human mesangial cells. Cultured human glomerular mesangial cells were made quiescent in RPMI 1640 medium containing 0.5% FCS for 24 hours prior to treatment with (A) 0 to 10 μmol/L tRA, (B) 0 to 5 μmol/L Dex, or (C) 0 to 5 μmol/L tRA and/or Dex for 24 hours. Total RNA was extracted and subject to Northern hybridization for MIF mRNA and 28S ribosomal RNA (rRNA). A representative Northern blot analysis is shown. Kidney International 2004 66, 2119-2131DOI: (10.1111/j.1523-1755.2004.66002.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 tRA increased LDL accumulation in pig smooth muscle cells: Oil Red O staining. Pig artery smooth muscle cells were cultured in RPMI 1640 medium containing 1% FCS for 24 hours and followed by a further 24 hours in RPMI 1640, 1% FCS supplemented with 200 μg/mL LDL in the absence (A) or presence (B) of 5 μmol/L tRA. Cells were washed three times with cold phosphate-buffered saline, fixed with 5% formalin and subjected to Oil Red O staining. The arrow in (B) points to an LDL droplet visualized by Oil Red O staining. Kidney International 2004 66, 2119-2131DOI: (10.1111/j.1523-1755.2004.66002.x) Copyright © 2004 International Society of Nephrology Terms and Conditions